Search results for "harm"

showing 10 items of 13866 documents

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of…

2019

Patrizia Alvisi,1 Serena Arrigo,2 Salvatore Cucchiara,3 Paolo Lionetti,4 Erasmo Miele,5 Claudio Romano,6 Alberto Ravelli,7 Daniela Knafelz,8 Stefano Martelossi,9 Graziella Guariso,10 Salvatore Accomando,11 Giovanna Zuin,12 Costantino De Giacomo,13 Lucio Balzani,14 Monia Gennari,15 Marina Aloi3 On behalf of the SIGENP IBD Working Group 1Pediatric Gastroenterology Unit, Pediatric Department, Maggiore Hospital, Bologna, Italy; 2Pediatric Gastroenterology and Endoscopy Unit, G Gaslini Children’s Hospital, Genoa, Italy; 3Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy; 4Gastroenterology and Nutrition Unit, Meyer Children’s Hospital, Florenc…

medicine.medical_specialtyPopulationadalimumab efficacy03 medical and health sciences0302 clinical medicineadalimumab efficacy; adalimumab safety; infliximab failure; pediatric crohn’s diseaseRheumatologyInternal medicinemedicineAdalimumabinfliximab failureImmunology and AllergyTargets and Therapy [Biologics]Pharmacology (medical)Adverse effecteducationPediatric gastroenterologyOriginal ResearchCrohn's diseaseeducation.field_of_studybusiness.industryAdalimumab efficacy; Adalimumab safety; Infliximab failure; Pediatric Crohn’s disease; Immunology and Allergy; Rheumatology; Oncology; Gastroenterology; Pharmacology (medical)Gastroenterologyadalimumab safetyHepatologymedicine.diseaseInfliximabOncology030220 oncology & carcinogenesisCohortpediatric Crohn’s disease030211 gastroenterology & hepatologybusinessmedicine.drugBiologics : Targets & Therapy
researchProduct

Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repagl…

2004

The 11 C-labeled sulfonylurea receptor 1 (SUR1) ligand (S)-2-(( 11 C)methoxy)-4-(3-methyl-1-(2-piperidine-1-yl-phenyl)- butyl-carbamoyl)-benzoic acid (( 11 C)methoxy-repaglinide) was synthesized in an overall radiochemical yield of 35% after 55 min with a radiochemical purity higher than 99%. This compound is considered for the noninvasive investigation of the SUR1 receptor status of pancreatic b-cells by positron emission tomography (PET) in the context of type 1 and type 2 diabetes. The specific activity was 40-70 GBq/lmol. In vitro testing of the nonradioactive methoxy-repaglinide was performed to characterize the affinity for binding to the human SUR1 isoform. Methoxy-repaglinide induce…

medicine.medical_specialtyPotassium Channelsmedicine.medical_treatmentReceptors DrugClinical BiochemistryPharmaceutical ScienceType 2 diabetesIn Vitro TechniquesSulfonylurea ReceptorsBiochemistryBenzoatesBinding CompetitiveIslets of LangerhansPiperidinesDiabetes mellitusInternal medicineDrug DiscoveryInsulin SecretionmedicineAnimalsHumansInsulinCarbon RadioisotopesPotassium Channels Inwardly RectifyingMolecular BiologyIC50Type 1 diabetesChemistryInsulinOrganic ChemistryStereoisomerismmedicine.diseaseRepaglinideLigand (biochemistry)RatsEndocrinologyPositron-Emission TomographyCOS CellsMolecular MedicineSulfonylurea receptorATP-Binding Cassette TransportersCarbamatesRadiopharmaceuticalsHydroxybenzoate Ethersmedicine.drugBioorganicmedicinal chemistry letters
researchProduct

Recent advances and disputes about curcumin in retinal diseases

2021

Abstract Curcumin belongs to the group of so-called phytocompounds, biologically active molecules produced by plants exerting a beneficial effect on health. Curcumin shows a wide spectrum of different properties, being an anti-inflammatory, antioxidant, antimicrobial and antimutagenic molecule. The purpose of the review is to examine what literature reported on the characteristics of curcumin, particularly, on the beneficial and controversial aspects of this molecule, aiming for a better therapeutic management of retinal diseases. The retina is a constant target of oxidative stress, this tissue being characterized by cells rich in mitochondria and by vessels and being, obviously, continuous…

medicine.medical_specialtyProliferative vitreoretinopathyantioxidant proprietiesReviewexosomesPharmacologymedicine.disease_causeRetinal ganglionanti-inflammatory proprieties; antioxidant proprieties; exosomes; miRNA; nanosphere; natural compounds03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOphthalmologymedicinenatural compoundsanti-inflammatory proprietiesmiRNARetinabusiness.industryRetinalDiabetic retinopathyMacular degenerationmedicine.diseasenanosphereOphthalmologymedicine.anatomical_structurechemistry030221 ophthalmology & optometryCurcuminbusiness030217 neurology & neurosurgeryOxidative stress
researchProduct

Medicated hydrogels of hyaluronic acid derivatives for use in orthopedic field.

2013

Physical hydrogels have been obtained from hyaluronic acid derivatized with polylactic acid in the presence or in the absence of polyethylene glycol chains. They have been extemporarily loaded with antibacterial agents, such as vancomycin and tobramycin. These medicated hydrogels have been used to coat titanium disks (chosen as simple model of orthopedic prosthesis) and in vitro studies in simulated physiological fluid have been performed as a function of time and for different drug loading and polymer concentration values. Sterilization process performed on the hydrogels does not change their rheological behavior and release properties as well as the chemical structure of starting copolyme…

medicine.medical_specialtyProsthesis-Related InfectionsPolymersPolyestersPharmaceutical SciencePolyethylene glycolengineering.materialProsthesis Designcomplex mixturesPolyethylene Glycolschemistry.chemical_compoundCoatingPolylactic acidVancomycinHyaluronic acidmedicineHumansOrthopedic ProceduresFemurLactic AcidHyaluronic AcidCells CulturedSkinchemistry.chemical_classificationTitaniumChemistrytechnology industry and agricultureSterilizationHydrogelsPolymerFibroblastsSurgeryAnti-Bacterial AgentsPolyesterSelf-healing hydrogelsengineeringTobramycinImplantRheologyBiomedical engineeringInternational journal of pharmaceutics
researchProduct

The evaluation of psychiatric drug therapy on oral lichen planus patients with psychiatric disorders

2008

Objectives: Current treatments of oral lichen planus are palliative, not curative. Because psychiatric disorders significantly influence the development and severity of oral lichen planus, the use of psychiatric drug therapy may be an adjunct in treatment. The purpose of this study was to determine the efficacy of drug therapy of psychiatric disorders in oral lichen planus. Study design: Our controlled clinical study consisted of forty-six patients with oral lichen planus and psychiatric disorders who were randomly divided into two groups. Both groups were given topical corticosteroids and the study group received additional psychiatric drug therapy. Patients were monitored for a period of …

medicine.medical_specialtyPsychiatric drug therapylaw.inventionClinical studyLesionPharmacotherapyRandomized controlled trialstomatognathic systemlawmedicineHumansSingle-Blind MethodPsychiatryGeneral Dentistrybusiness.industryMental DisordersTreatment methodmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Response to treatmentstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusmedicine.symptombusinessLichen Planus Oral
researchProduct

Adverse effects of iodine thyroid blocking: a systematic review

2011

(131)I, when released in a radiological or nuclear accident as happened recently in Fukushima, Japan, may cause thyroid cancer as a long-term consequence. Iodine thyroid blocking (ITB) is known to reduce the risk of developing thyroid cancer. Potential adverse effects of ITB have not been systematically investigated so far. This article summarises the results of a review on adverse effects of ITB based on a systematic literature search in scientific medical databases. A meta-analysis was not performed as identified studies displayed major heterogeneity. The search resulted in 14 articles relevant to the topic, reporting mostly on surveys, ecological and intervention studies. Only one study …

medicine.medical_specialtyPsychological interventionMEDLINEContext (language use)Health careThyroid Diseases/chemically inducedMedicineHumansRadiology Nuclear Medicine and imagingThyroid NeoplasmsIntensive care medicineAdverse effectThyroid cancerRadiationRadiological and Ultrasound Technologybusiness.industryPotassium IodidePublic Health Environmental and Occupational HealthCase-control studyGeneral MedicinePharmacoepidemiologymedicine.diseasePotassium Iodide/adverse effectsThyroid DiseasesReview Literature as TopicCase-Control StudiesThyroid Neoplasms/drug therapybusiness
researchProduct

Predictors of increase in physical activity during a 6-month follow-up period among overweight and physically inactive healthy young adults

2015

Abstract Background/Objective The beneficial effects of physical activity (PA) are well known, but it remains challenging to increase PA among physically inactive and overweight young individuals. The present study aimed to examine how selected psychological and physical characteristics assessed at baseline predict the increase in total PA over a 6-month follow-up among 51 physically inactive and overweight adults (20 women, 31 men; age 26–40 years) who participated in a lifestyle counselling study without supervised PA sessions. Methods Baseline measurements included a questionnaire assessment of sense of coherence and psychological flexibility, heart rate monitoring-based stress/recovery …

medicine.medical_specialtyPsychological interventionPharmaceutical SciencePharmacology (nursing)Physical Therapy Sports Therapy and RehabilitationOverweightLogistic regressionMetabolic equivalentlcsh:GV557-1198.995RecoverymedicineObesityYoung adultta315lcsh:SportsPhysical inactivitybusiness.industryPhysical activityPublic Health Environmental and Occupational HealthOdds ratiota3142medicine.diseaseObesityConfidence intervalSense of coherencePhysical therapyOriginal Articlemedicine.symptombusinessJournal of Exercise Science & Fitness
researchProduct

The concept of major depression. II. Agreement between six competing operational definitions in 600 psychiatric inpatients.

1991

Six operational definitions of the concept of major depression were submitted to empirical evaluation in 600 psychiatric inpatients. Special attention was given to the comparison of major depression in DSM-III-R and ICD-10. The data base created by a polydiagnostic interview revealed relevant classificatory differences between the six definitions under study. Sources of different diagnostic base rates were: inclusion or omission of anhedonia as an obligatory mood criterion; minimal number of syndrome criteria required for the syndrome diagnosis; different width and reference points of time criteria; exclusion rules for co-existing schizophrenic symptoms and for previous nonaffective and man…

medicine.medical_specialtyPsychometricsPsychometricsmedia_common.quotation_subjectGermanymedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryDepression (differential diagnoses)media_commonPsychiatric Status Rating ScalesDepressive DisorderOperational definitionGeneral NeuroscienceAnhedoniaGeneral MedicineSyndromeAgreementHospitalizationPsychiatry and Mental healthNeuropsychology and Physiological PsychologyMoodMild depressionmedicine.symptomPsychologyKappaEuropean archives of psychiatry and clinical neuroscience
researchProduct

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

2017

AbstractTherapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the interindividual variability of pharmacokinetics and thus enables personalized pharmacotherapy. In psychiatry and neurology, patient populations that may particularly benefit from TDM are children and adolescents, pregnant women, elderly patients, individuals with intellectual disabilities, patients with substance abuse disorders, forensic psychiatric patients or patients with known or suspected pharmacokinetic abnormalities. Non-response at therapeutic doses, uncertain drug adherence, suboptimal tolerability, or pharmacokinetic drug…

medicine.medical_specialtyPsychopharmacologyGuidelines as Topic030226 pharmacology & pharmacy03 medical and health sciencesNeuropharmacology0302 clinical medicinePharmacotherapyHealth caremedicineHumansPharmacology (medical)PsychiatryIntensive care medicinePsychotropic Drugsmedicine.diagnostic_testbusiness.industryMental DisordersGeneral Medicinemedicine.disease3. Good healthAntiparkinson drugNeuropsychopharmacologySubstance abusePsychiatry and Mental healthTolerabilityTherapeutic drug monitoringDrug Monitoringbusiness030217 neurology & neurosurgeryPharmacogeneticsPharmacopsychiatry
researchProduct

Mechanism of New Antipsychotic Medications

2003

Antagonism of D 2 -like dopamine receptors is the putative mechanism underlying the antipsychotic efficacy of psychotropic drugs. Positron emission tomographic studies suggest that the antipsychotic effect of dopamine receptor antagonists occurs within a therapeutic window between 60% and 80%(striatal) D 2 receptor occupancy. The incidence of extrapyramidal side effects increases above the 80% threshold. However, the novel atypical antipsychotic drug, aripiprazole, occupies up to 95% of striatal D 2 -like dopamine receptors at clinical doses, and the incidence of extrapyramidal side effects with aripiprazole is no higher than with placebo. The most likely explanation for this finding is ari…

medicine.medical_specialtyPsychosismedicine.drug_classmedicine.medical_treatmentAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistPiperazinesBasal Ganglia DiseasesArts and Humanities (miscellaneous)Dopamine receptor D2Internal medicinemedicineHumansAntipsychoticDose-Response Relationship DrugReceptors Dopamine D2Putamenmedicine.diseaseCorpus StriatumProlactinDopamine D2 Receptor AntagonistsPsychiatry and Mental healthEndocrinologyMechanism of actionDopamine receptorSchizophreniaAripiprazolemedicine.symptomPsychologyAntipsychotic AgentsTomography Emission-Computedmedicine.drugArchives of General Psychiatry
researchProduct